Eric C. Klawiter - Concepedia

Author

Eric C. Klawiter

Also Known As

Christina Azevedo, E. C. Klawiter, E. Klawiter, E.C. Klawiter, Eric C Klawiter, Eric C. Klawiter, Eric Klawiter, Frederik Barkhof, Klawiter EC, Roland G. Henry

179

Publications

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Athinoula A. Martinos Center for Biomedical Imaging Washington University in St. Louis Beth Israel Deaconess Medical Center

About

Eric C. Klawiter is an author at Massachusetts General Hospital specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Health Sciences	5	5	376
3	Engineering	4	4	413
4	Social Sciences	2	2	36
5	Public Health	1	1	16

Eric C. Klawiter

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords Eric C. Klawiter, Robert E. Schmidt, Kathryn Trinkaus, NeuroImage Radial DiffusivitySpinal Cord InjuryNeurological DisorderNeuroanatomyNeurological Function	2011	361
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis Robert J. Fox, Christopher S. Coffey, Robin Conwit, New England Journal of Medicine	2018	270
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis Robert T. Naismith, Nhial T. Tutlam, Junqian Xu, Neurology	2009	200
Neuroinflammatory component of gray matter pathology in multiple sclerosis Elena Herranz, Costanza Giannì, Céline Louapre, Annals of Neurology	2016	193
In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis Tobias Granberg, Qiuyun Fan, Constantina A. Treaba, Brain EngineeringNeurological DisorderWhite MatterBiomedical EngineeringNeurology	2017	181
Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis Robert T. Naismith, Nhial T. Tutlam, Junqian Xu, Neurology	2009	143
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial John R. Corboy, Robert J. Fox, Ilya Kister, The Lancet Neurology Disease ProgressionNeurological DisorderMedicineNew Disease ActivityClinical Trials	2023	126
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions Enrique Álvarez, Laura Piccio, Robert Mikesell, Multiple Sclerosis Journal ImmunodeficienciesImmunologyImmune RegulationPathologyNeuroinflammation	2013	123
Association of Neuromyelitis Optica With Severe and Intractable Pain Peiqing Qian, Samantha Lancia, Enrique Álvarez, Archives of Neurology	2012	96
High-gradient diffusion MRI reveals distinct estimates of axon diameter index within different white matter tracts in the in vivo human brain Susie Y. Huang, Qiyuan Tian, Qiuyun Fan, Brain Structure and Function NeuroanatomyWhite MatterBiomedical ImagingHigh-gradient Diffusion MriBrain Mapping	2019	87

Page 1